Bumetanide in the treatment of hepatic ascites. A short and long-term study.
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000150:complications; D001201:Ascites / Q000188:drug therapy* / Q000209:etiology; D001565:Benzoates / Q000627:therapeutic use*; D002082:Butylamines / Q000627:therapeutic use; D003864:Depression, Chemical; D004232:Diuretics / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010647:Phenyl Ethers / Q000627:therapeutic use; D013268:Stimulation, Chemical; D013449:Sulfonamides; D013997:Time Factors; D014882:Water-Electrolyte Balance / Q000187:drug effects
D001565:Benzoates; D002082:Butylamines; D004232:Diuretics; D010647:Phenyl Ethers; D013449:Sulfonamides